Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133. Case and Commentary Dec 2005 Media Attention to End-of-Life Cases, Commentary 1 Ware G. Kuschner, MD Virtual Mentor. 2005;7(12):775-779. doi: 10.1001/virtualmentor.2005.7.12.ccas1-0512. Case and Commentary Dec 2005 Media Attention to End-of-Life Cases, Commentary 2 John J. Paris, SJ, PhD Virtual Mentor. 2005;7(12):779-782. doi: 10.1001/virtualmentor.2005.7.12.ccas1-0512.
Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133.
Case and Commentary Dec 2005 Media Attention to End-of-Life Cases, Commentary 1 Ware G. Kuschner, MD Virtual Mentor. 2005;7(12):775-779. doi: 10.1001/virtualmentor.2005.7.12.ccas1-0512.
Case and Commentary Dec 2005 Media Attention to End-of-Life Cases, Commentary 2 John J. Paris, SJ, PhD Virtual Mentor. 2005;7(12):779-782. doi: 10.1001/virtualmentor.2005.7.12.ccas1-0512.